Aeon Biopharma
AEON Biopharma develops ABP-450, a proprietary botulinum toxin aimed at treating different nervous system-related disorders, including migraines and cervical dystonia.
Specifications
- LocationCalifornia, USA
- Content Platform
- Colors
AEON Biopharma develops ABP-450, a proprietary botulinum toxin aimed at treating different nervous system-related disorders, including migraines and cervical dystonia.
